Document Mentions (4 shared documents)

EFTA00136746

2 mentions1 same-page

Page ?Same page

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

vv.reuters.com/article/us-armenia-azerbaijan/france-and-turkey-at-odds-as-karabakh-fighting- divides-nato-allies-idUSICBN26L106> (9/30, Hovhannisyan, Bagirova) reports France and Turkey "traded angry recriminations on Wednesday as international tensions mounted over" the clashes in Nagorno-Karabakh. Some

EFTA00135712

2 mentions1 same-page

Page ?Same page

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ize Nagorno- Karabakh as independent, a move that could further interfere with a potential settlement of the dispute." Reuters (9/30, Hovhannisyan, Bagirova) reports France and Turkey "traded angry recriminations on Wednesday as international tensions mounted over" the clashes in Nagorno- Karabakh. Some

EFTA00148896

2 mentions1 same-page

Page ?Same page

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

nize Nagorno-Karabakh as independent, a move that could further interfere with a potential settlement of the dispute." Reuters (9/30, Hovhannisyan, Bagirova) reports France and Turkey "traded angry recriminations on Wednesday as international tensions mounted over" the clashes in Nagorno- Karabakh. Some